Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: France Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20112
20151
20163
20171
20203
20212
20223
20231
20245
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Terminated4
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Amgen2
ADC Therapeutics S.A.1
Bayer1
Boehringer Ingelheim1
Cantargia AB1
Centre Antoine Lacassagne1
Centre Georges Francois Leclerc1
Centre Leon Berard1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms27
Carcinoma, Non-Small-Cell Lung8
Colorectal Neoplasms7
Neoplasm Metastasis7
Triple Negative Breast Neoplasms7
Ovarian Neoplasms6
Breast Neoplasms5
Endometrial Neoplasms5
Esophageal Neoplasms5
Lung Neoplasms5

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.